These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 14975372)

  • 21. The beneficial effects of statins in autoimmune disease therapy.
    Marai I; Shoenfeld Y
    Drug News Perspect; 2007 Apr; 20(3):165-9. PubMed ID: 17520093
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [New methods of therapy for ocular inflammatory autoimmune diseases].
    Kubicka-Trzaska A; Undas A
    Klin Oczna; 2003; 105(6):428-32. PubMed ID: 15049272
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Type I interferons as immunoregulatory molecules; implications for therapy in experimental autoimmune uveoretinitis.
    Mizuguchi J; Takeuchi M; Usui M
    Arch Immunol Ther Exp (Warsz); 2002; 50(4):243-54. PubMed ID: 12371620
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Treatment of posterior noninfectious uveitis : Current situation and future developments].
    Pleyer U; Pohlmann D; Stübiger N
    Ophthalmologe; 2016 May; 113(5):380-90. PubMed ID: 27165275
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of tumour necrosis factor (TNF-alpha) in experimental autoimmune uveoretinitis (EAU).
    Dick AD; Forrester JV; Liversidge J; Cope AP
    Prog Retin Eye Res; 2004 Nov; 23(6):617-37. PubMed ID: 15388077
    [TBL] [Abstract][Full Text] [Related]  

  • 26. alpha-Galactosylceramide therapy for autoimmune diseases: prospects and obstacles.
    Van Kaer L
    Nat Rev Immunol; 2005 Jan; 5(1):31-42. PubMed ID: 15630427
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nicotine could augment adhesion molecule expression in human endothelial cells through macrophages secreting TNF-alpha, IL-1beta.
    Wang Y; Wang L; Ai X; Zhao J; Hao X; Lu Y; Qiao Z
    Int Immunopharmacol; 2004 Dec; 4(13):1675-86. PubMed ID: 15454119
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intravenous immunoglobulin and autoimmunity.
    Zandman-Goddard G
    Isr Med Assoc J; 2010 Jan; 12(1):45-6. PubMed ID: 20450130
    [No Abstract]   [Full Text] [Related]  

  • 29. The mosaic of autoimmunity: prediction, autoantibodies, and therapy in autoimmune diseases--2008.
    Shoenfeld Y; Blank M; Abu-Shakra M; Amital H; Barzilai O; Berkun Y; Bizzaro N; Gilburd B; Zandman-Goddard G; Katz U; Krause I; Langevitz P; Mackay IR; Orbach H; Ram M; Sherer Y; Toubi E; Gershwin ME
    Isr Med Assoc J; 2008 Jan; 10(1):13-9. PubMed ID: 18300564
    [No Abstract]   [Full Text] [Related]  

  • 30. Cannabinoids, loratadine and allopurinol as novel additions to the antipsoriatic ammunition.
    Namazi MR
    J Eur Acad Dermatol Venereol; 2005 May; 19(3):319-22. PubMed ID: 15857457
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Glabridin suppresses intercellular adhesion molecule-1 expression in tumor necrosis factor-alpha-stimulated human umbilical vein endothelial cells by blocking sphingosine kinase pathway: implications of Akt, extracellular signal-regulated kinase, and nuclear factor-kappaB/Rel signaling pathways.
    Kang JS; Yoon YD; Han MH; Han SB; Lee K; Lee KH; Park SK; Kim HM
    Mol Pharmacol; 2006 Mar; 69(3):941-9. PubMed ID: 16354764
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synergistic effect of rapamycin and cyclosporin A in the treatment of experimental autoimmune uveoretinitis.
    Martin DF; DeBarge LR; Nussenblatt RB; Chan CC; Roberge FG
    J Immunol; 1995 Jan; 154(2):922-7. PubMed ID: 7814893
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunosuppressive therapy of experimental uveitis.
    Smecka Z; Smecková M
    Acta Univ Palacki Olomuc Fac Med; 1984; 107():171-7. PubMed ID: 6242640
    [No Abstract]   [Full Text] [Related]  

  • 34. Sphingosine 1-phosphate receptors mediate stimulatory and inhibitory signalings for expression of adhesion molecules in endothelial cells.
    Kimura T; Tomura H; Mogi C; Kuwabara A; Ishiwara M; Shibasawa K; Sato K; Ohwada S; Im DS; Kurose H; Ishizuka T; Murakami M; Okajima F
    Cell Signal; 2006 Jun; 18(6):841-50. PubMed ID: 16111867
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tumour necrosis factor alpha down-regulation parallels inflammatory regression in ulcerative colitis patients treated with infliximab.
    Hassan C; Ierardi E; Burattini O; De Francesco V; Zullo A; Stoppino G; Panella C; Morini S
    Dig Liver Dis; 2007 Sep; 39(9):811-7. PubMed ID: 17652038
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of cyclosporine on T-cell subsets in experimental autoimmune uveitis.
    Nussenblatt RB; Scher I
    Invest Ophthalmol Vis Sci; 1985 Jan; 26(1):10-4. PubMed ID: 3871429
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of autoimmune uveitis.
    Whitcup SM; Nussenblatt RB
    Ann N Y Acad Sci; 1993 Nov; 696():307-18. PubMed ID: 8109836
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Aspects of molecular immunology and immunogenetics in autoimmune uveitis].
    Istrate B
    Oftalmologia; 2012; 56(4):34-8. PubMed ID: 23755515
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oral tolerance in autoimmune uveitis.
    Wildner G; Thurau SR
    Dev Ophthalmol; 1999; 31():67-76. PubMed ID: 10641200
    [No Abstract]   [Full Text] [Related]  

  • 40. Study of the role of P2Y receptors in the development of experimental autoimmune uveitis.
    Relvas LJ; Villermain F
    Bull Soc Belge Ophtalmol; 2011; (317):57. PubMed ID: 21560861
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.